. Author manuscript; available in PMC: 2011 Nov 15.

Published in final edited form as: Mov Disord. 2010 Nov 15;25(15):2571–2576. doi: 10.1002/mds.23330

TABLE 2.

Baseline characteristics of LRRK2 mutation carriers and controls

	LRRK2 carriers (n=6)	Control subjects (n=30)	All subjects (n=36)
UPDRS-III^*	6.2 ± 6.9 (1-19)	4.5 ± 6.6 (1-30)	4.8 ± 6.6 (1-30)
Trails B speed^**	42.0 ± 8.9	31.0 ± 3.1	36.0 ± 8.4
CDR^*	0.1 ± 0.2	0.1 ± 0.2	0.1 ± 0.2
BIMC^*	0.8 ± 0.7	2.3 ± 2.4	2.1 ± 2.3
FCSRT^* (free recall)	31.8 ± 3.2	31.6 ± 5.4	31.6 ± 5.1

LRRK2: Leucine Rich Repeat Kinase 2; UPDRS-III: Unified Parkinson's Disease Rating Scale, motor subscale, mean±SD (range); CDR: Clinical Dementia Rating Scale, mean±SD; BIMC: Blessed Information Memory Concentration test, mean±SD; FCSRT: Free and Cued Selective Reminding test, mean±SD.

p>0.05;

^**

p=0.02